Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial)

The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)

(2013) Giorgio Gandaglia et al.   BJU INTERNATIONAL

Is chronic prostatic inflammation a new target in the medical therapy of lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH)?

(2013) Vincenzo Ficarra   BJU INTERNATIONAL

Serenoa Repens, Lycopene and Selenium: A Triple Therapeutic Approach to Manage Benign Prostatic Hyperplasia

(2013) L. Minutoli et al.   CURRENT MEDICINAL CHEMISTRY

EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

(2013) Matthias Oelke et al.   EUROPEAN UROLOGY

Hexanic lipidosterolic extract ofSerenoa repensinhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1,in vitro

(2012) Alain Latil et al.   BJU INTERNATIONAL

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review

(2012) Roderick MacDonald et al.   BJU INTERNATIONAL

The Combination of Serenoa Repens, Selenium and Lycopene is More Effective Than Serenoa Repens Alone to Prevent Hormone Dependent Prostatic Growth

(2011) Domenica Altavilla et al.   JOURNAL OF UROLOGY

Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

(2011) Kevin T. McVary et al.   JOURNAL OF UROLOGY

Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Category IIIA with Serenoa repens plus Selenium and Lycopene (Profluss®) versus S. repens Alone: An Italian Randomized Multicenter-Controlled Study

(2010) G. Morgia et al.   UROLOGIA INTERNATIONALIS

Effect of Serenoa repens, Lycopene, and Selenium on Proinflammatory Phenotype Activation: An In Vitro And In Vivo Comparison Study

(2010) Giulio Bonvissuto et al.   UROLOGY

The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study

(2009) Claus G. Roehrborn et al.   EUROPEAN UROLOGY

N20 Tamsulosin with or without serenoa repens in benign prostatic hyperplasia: The Comb TAMSR trial

(2009) D. Argirovic   EUROPEAN UROLOGY SUPPLEMENTS

A Prospective Study of Lower Urinary Tract Symptoms and Erectile Dysfunction

(2008) Alison M. Mondul et al.   JOURNAL OF UROLOGY

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

(2007) J. Curtis Nickel et al.   EUROPEAN UROLOGY

Relationship Between Lower Urinary Tract Symptoms and Erectile Dysfunction: Results From the Boston Area Community Health Survey

(2007) Sara T. Brookes et al.   JOURNAL OF UROLOGY

The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT Study

(2007) Claus G. Roehrborn et al.   JOURNAL OF UROLOGY